Search Result

Search Tags:  Supernus Pharmaceuticals Inc.

FDA approves Supernus' epilepsy drug Oxtellar XR

Supernus Pharmaceuticals Inc. said Monday that the Food and Drug Administration approved its once- per-day epilepsy drug Oxtellar XR. Its shares jumped more than 10 percent in morning trading.

Monday - 10/22/2012, 11:52am EDT

Tags: FDA, epilepsy